Phadisco
Phadisco Ltd is a Cyprus-based pharmaceutical distributor, founded 1966, exclusively distributing branded pharmaceuticals, medical devices, diagnostics, and infant nutrition for principals such as Johnson & Johnson, Eli Lilly, Nestl\u00e9, and GE Healthcare across Cyprus and nine export markets.
- Company typePrivate
- Founded1966
- HeadquartersLatsia, Cyprus
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Phadisco does
Phadisco Ltd is a privately held pharmaceutical distribution company headquartered in Latsia, Cyprus, operating as a subsidiary of the Christodoulides Bros group, which traces its origins to 1933. Founded in 1966, Phadisco distributes branded pharmaceuticals, medical equipment, medical devices, diagnostics equipment, and infant nutrition products as the exclusive representative for Tier-1 principals including Johnson & Johnson, Eli Lilly, Nestl\u00e9, GE Healthcare, Zeiss, Boston Scientific, Ortho Clinical Diagnostics, Wyeth, Lifespine, Scanlan, Americare, and Gruppo Pediatrica. Its product portfolio also includes legacy Eli Lilly brands (Nuseals, Keflex, Ceclor, Tapazole, Kefzol) acquired in 2003 and distributed under contract manufacturing arrangements across nine export markets.
The company operates through a sales-led GTM motion built on dedicated Clinical Support and Medical Representative teams covering physicians, diagnostic centres and hospitals across Cyprus, plus a Pharmacy Sales team that visits 100% of private pharmacies island-wide. Distribution is executed through a tri-channel architecture: direct distribution to the medical sector (including cold-chain and non-cold-chain products and Ministry of Health channels), indirect pharmacy distribution via sister company Pharmalink, and mass-market OTC distribution via sister company Christodoulides Bros. Operations are anchored by a state-of-the-art climate-, fire-, and access-controlled warehouse supporting both cold-chain and ambient pharmaceutical storage, a 24/7 service engineering function for medical equipment, and a Quality department that enforces SOPs and an audited pharmacovigilance system.
The revenue model is transaction-based distribution: Phadisco earns fees and margins on the exclusive sale and promotion of principal products in Cyprus and across export markets in Malta, Slovenia, Lebanon, Jordan, Kuwait, Bahrain, UAE, and Qatar, with prospective expansion into Libya and Iraq. Headcount stands at 80+ covering sales, marketing, logistics, service, scientific support, and distribution. The company has received a US State Department Commercial Diplomacy Award and recurring Distributor of the Year awards from its principals.
Phadisco firmographics
Firmographics- Name
- Phadisco
- Legal name
- Phadisco Ltd
- Website
- https://phadisco.com.cy
- Company type
- Private
- Founded year
- 1966
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Phadisco Ltd is a Cyprus-based pharmaceutical distributor, founded 1966, exclusively distributing branded pharmaceuticals, medical devices, diagnostics, and infant nutrition for principals such as Johnson & Johnson, Eli Lilly, Nestl\u00e9, and GE Healthcare across Cyprus and nine export markets.
- Ownership category
- akta.pro rank
Phadisco industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industry
- Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)
Keywords
Where Phadisco is headquartered
LocationHeadquarters
- HQ city
- Latsia
- HQ country
- Cyprus
- HQ region
- Europe
Offices1 record
Markets served
Phadisco business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Pharmaceutical Distribution: Exclusive distribution and sales of branded pharmaceuticals, medical equipment, medical devices, diagnostics equipment and infant nutrition products in Cyprus and export markets.
- Product Distribution Agreements: Distribution agreements with pharmaceutical companies for distribution and promotion of their products in Cyprus, Malta, Slovenia, Lebanon, Jordan, Kuwait, Bahrain, UAE, Qatar and prospective markets.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Phadisco product offering
Product offeringCore offering
Phadisco Ltd is a pharmaceutical distribution company operating in Cyprus that holds exclusive distribution and sales rights for branded pharmaceuticals, medical equipment, medical devices, diagnostics equipment, and infant nutrition products from major international principals. The company supports healthcare providers through field-based clinical and pharmacy sales teams and operates a state-of-the-art climate-controlled warehouse with cold chain logistics, backed by a 24/7 service engineering department and a full pharmacovigilance system.
Product overview
Phadisco is a pharmaceutical distribution company operating as a unified product portfolio across five core areas: Pharmaceuticals, Diagnostics & Medical Equipment, Medical Surgical Devices & Consumables, Nutritional Products, and Infant Milk Formula. The company distributes branded pharmaceuticals acquired from Eli Lilly (Nuseals, Keflex, Ceclor, Tapazole, Kefzol) and represents major international principals including Johnson & Johnson, Eli Lilly, Zeiss, GE Healthcare, Ortho Clinical Diagnostics, Boston Scientific, Lifespine, Scanlan, Wyeth, and Gruppo Pediatrica. Operations are supported by a dedicated service department offering 24/7 technical support, a climate-controlled warehouse with distribution capabilities, and quality/regulatory affairs functions including pharmacovigilance. The company serves the Cypriot market and exports to multiple Mediterranean and Middle Eastern territories.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Services
- Diagnostics & Medical Equipment Distribution
- Medical Surgical Devices & Consumables Distribution
- Nutritional Products Distribution Distribution of nutritional supplements and products in the Cypriot market, including partnerships with Gruppo Paediatrica and Wyeth Nutrition.
- Infant Milk Formula Distribution Exclusive distribution of Nestlé infant milk formula products in Cyprus, including brands such as S-26 GOLD 1, supported by pharmacovigilance and recall handling capability.
- Overseas Operations / Export Distribution International distribution and export services for Eli Lilly legacy products (Nuseals, Keflex, Ceclor, Tapazole, Kefzol) extending to Malta, Slovenia, Lebanon, Jordan, Kuwait, Bahrain, UAE, and Qatar, with prospective expansion into Libya and Iraq.
Companies that use Phadisco
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Phadisco technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Phadisco partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core.
- Eli LillycoreIn 2003 Phadisco acquired a number of legacy products from Eli Lilly which are produced under contract manufacturing agreements. Products include Nuseals, Keflex, Ceclor, Tapazole, Kefzol distributed in Cyprus, Malta, Slovenia, Lebanon, Jordan, Kuwait, Bahrain, UAE and Qatar.
- Johnson & JohnsoncorePharmaceutical distribution partnership for branded pharmaceuticals in Cyprus.
- NestlécoreExclusive distribution of Nestlé infant milk formula products in Cyprus. Phadisco handles voluntary recall of specific infant formula batches due to potential presence of cereulide.
- GE HealthcarecoreDistribution of GE Voluson ultrasound equipment in Cyprus. Phadisco organizes training events like GE Voluson Ultrasounds Users Day for gynecologists.
- ZeisscoreMedical equipment distribution partnership for optical and medical technology products.
- Boston ScientificcoreMedical devices distribution partnership for interventional medical devices.
- Ortho Clinical DiagnosticscoreDiagnostics equipment distribution partnership for clinical diagnostics products.
- WyethcoreInfant formula milk distribution partnership through Wyeth Nutrition.
- AmericarecoreHealthcare products distribution partnership.
- LifespinecoreMedical devices distribution partnership for spinal care products.
- ScanlancoreMedical surgical devices distribution partnership.
- Gruppo PaediatricacoreNutritional products distribution partnership.
- PharmalinkcorePartner company performing indirect distribution to pharmacies for cold chain and non-cold pharmaceutical products.
- Christodoulides BroscoreSister company handling sales of OTC products to mass market channel. Also handles sales of Phadisco's OTC products to mass market.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Phadisco competitors and assessment
Company assessmentBroad incumbents
- Phoenix Group: European pharmaceutical wholesale and distribution group operating across multiple European markets. Comparable as a larger pharma distribution platform with GDP-compliant logistics.
- McKesson: Global pharmaceutical distributor and healthcare services company. Relevant as a broad incumbent setting distribution standards and competing for principal contracts worldwide.
- Alliance Healthcare: Wholesale distributor owned by Walgreens Boots Alliance, serving pharmacies and healthcare providers across Europe. Broad incumbent in pharmaceutical wholesale that competes for principal mandates of similar scale.
Direct peers
- Geo. Pavlides & Araouzos: Cyprus-based distributor with healthcare, pharmaceutical, and consumer goods lines. Comparable as a multi-channel Cypriot distributor operating in similar customer segments.
- C.A. Papaellinas & Co: Established Cypriot distributor of pharmaceuticals, consumer health, and medical products. Directly comparable as another long-standing Cyprus-based healthcare distributor serving pharmacies and hospitals.
- Remedica: Cyprus-based pharmaceutical manufacturer and distributor with regional export footprint. Directly comparable as another Cypriot pharma company operating in branded generics and distribution across MENA.
- Medochemie: Cyprus-headquartered pharmaceutical company with manufacturing and distribution operations across multiple therapeutic categories and export markets. Closest direct comparable in geography, scale, and pharma focus.
Emerging players
- Christodoulides Bros: Parent/sister company of Phadisco handling OTC and consumer health distribution in Cyprus mass market channel. Comparable as part of the same group with overlapping healthcare product distribution.
Others
- GSK Cyprus / Regional Distribution: Major pharmaceutical principal with established distribution partnerships across Cyprus and the Middle East. Relevant ecosystem participant as both a current/prospective principal of Phadisco and a comparator for distribution structures.
Regional players
- Astellas Pharma Middle East: Regional pharmaceutical operations covering Middle East and North Africa. Comparable as a pharma principal that partners with local distributors like Phadisco for in-country representation.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Phadisco social profiles
Digital presencePhadisco financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phadisco leadership team
Management profileNumber of profiles
Phadisco subsidiaries and ownership
Company hierarchySubsidiaries2 records
Phadisco funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phadisco M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phadisco
What does Phadisco do?
Phadisco Ltd is a pharmaceutical distribution company operating in Cyprus that holds exclusive distribution and sales rights for branded pharmaceuticals, medical equipment, medical devices, diagnostics equipment, and infant nutrition products from major international principals. The company supports healthcare providers through field-based clinical and pharmacy sales teams and operates a state-of-the-art climate-controlled warehouse with cold chain logistics, backed by a 24/7 service engineering department and a full pharmacovigilance system.
Is Phadisco a public or private company?
Phadisco is a private company. It is classified as family owned and is currently operating.
When was Phadisco founded?
Phadisco was founded in 1966. It employs 51 to 100 people.
Where is Phadisco based?
Phadisco is headquartered in Latsia, Cyprus, in the Europe region.
How does Phadisco make money?
Two revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are product Distribution Agreements.
Who are Phadisco's main competitors?
Broad incumbents on record are Phoenix Group, McKesson and Alliance Healthcare. Direct peers are Geo. Pavlides & Araouzos, C.A. Papaellinas & Co, Remedica and Medochemie. Christodoulides Bros is listed as an emerging player. GSK Cyprus / Regional Distribution is listed as an others. Astellas Pharma Middle East is listed as a regional player.
Does Phadisco have an API?
No public API is recorded for Phadisco.
What industry is Phadisco in?
Phadisco's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant). Its NAICS code is 42421 and its SIC code is 5122.